Pramipexole Dihydrochloride
Overview
Pramipexole Dihydrochloride is a dopamine agonist primarily used in the treatment of Parkinson's disease and restless legs syndrome. It works by stimulating dopamine receptors in the brain, thereby alleviating symptoms associated with dopamine deficiency.
API suppliers (2)
Suppliers of Pramipexole Dihydrochloride evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
2 of 2 hold a GMP certificate on record in the EU or UK registers
- Hetero Drugs LimitedIndia1 active DMF GMP on record
- ORBION PHARMACEUTICALS PRIVATE LTDIndia1 active DMF GMP on record
Chemical identity
- IUPAC name
- 4-(3-cyclopentyloxy-4-methoxyphenyl)pyrrolidin-2-one
- Canonical SMILES
- COC1=C(C=C(C=C1)C2CC(=O)NC2)OC3CCCC3
- InChIKey
- HJORMJIFDVBMOB-UHFFFAOYSA-N
Therapeutic areas
Do you supply Pramipexole Dihydrochloride? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.